Transplantation of a human induced pluripotent stem cell-derived airway epithelial cell sheet into the middle ear of rats

Takeshi Tada,Hiroe Ohnishi,Norio Yamamoto,Fumihiko Kuwata,Yasuyuki Hayashi,Hideaki Okuyama,Tsunetaro Morino,Yoshiyuki Kasai,Hiromi Kojima,Koichi Omori

DOI: https://doi.org/10.1016/j.reth.2022.01.001

2022-01-14

Abstract:Introduction: Early postoperative regeneration of the middle ear mucosa is essential for the prevention of postoperative refractory otitis media and recurrent cholesteatoma. As a means for intractable otitis media management, we focused on human induced pluripotent stem cell (hiPSC)-derived airway epithelial cells (AECs), which have been used in upper airway mucosal regeneration and transplantation therapy. In this study, we transplanted hiPSC-derived AECs into the middle ear of immunodeficient rats. Methods: Following the preparation of AEC sheets from hiPSCs, the bilateral middle ear mucosa of X-linked severe combined immunodeficient rats was scraped, and the AEC sheets were transplanted in the ears unilaterally. Results: Human nuclear antigen (HNA)-positive ciliated cells were observed on the transplanted side of the middle ear cavity surface in three of six rats in the 1-week postoperative group and in three of eight rats in the 2-week postoperative group. No HNA-positive cells were found on the control side. The percentage of HNA-positive ciliated cells in the transplanted areas increased in the 2-week postoperative group compared with the 1-week group, suggesting survival of hiPSC-derived AECs. Additionally, HNA-positive ciliated cells were mainly located at sites where the original ciliated cells were localized. Immunohistochemical analysis showed that the transplanted AECs contained cytokeratin 5- and mucin 5AC-positive cells, indicating that both basal cells and goblet cells had regenerated within the middle ear cavity. Conclusions: The results of this study are an important first step in the establishment of a novel transplantation therapy for chronic otitis media.